WallStSmart
PTHS

Pelthos Therapeutics Inc.

NYSE MKT: PTHS · HEALTHCARE · BIOTECHNOLOGY

$25.09
+0.48% today

Updated 2026-04-29

Market cap
$83.79M
P/E ratio
P/S ratio
4.99x
EPS (TTM)
$-23.04
Dividend yield
52W range
$9 – $38
Volume
0.0M

Pelthos Therapeutics Inc. (PTHS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-83.4%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-2046.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-12.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-13.9%
2026-03-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-6.87-64.3%$24.08$20.74-13.9%
2025-11-13$-5.30-829.8%$37.40$33.61-10.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-4.18$-6.87-64.3%$9.39M
2025-09-30$-0.57$-5.30-829.8%$7.41M
2025-06-30$-6.26$-5.38+14.1%
2025-03-31$-3.21
2024-12-31$0.00$-0.32
2024-09-30$-2.30$-2.90-26.1%
2024-06-30$-2.90$-3.10-6.9%
2024-03-31$-5.50

Frequently asked questions

Has Pelthos Therapeutics Inc. beaten earnings estimates?
Pelthos Therapeutics Inc. has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -83.4% over the last 3 quarters.
How does PTHS stock react to earnings?
PTHS stock has moved an average of -12.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.